These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy]. Raffray L; Rivière P; Bonnet H; Duffau P; Longy-Boursier M Rev Med Interne; 2015 Sep; 36(9):626-30. PubMed ID: 25467298 [TBL] [Abstract][Full Text] [Related]
4. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients. Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036 [TBL] [Abstract][Full Text] [Related]
5. Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report. Park CH; Jang MA; Ahn YH; Hwang YY; Ki CS; Lee NY Korean J Lab Med; 2011 Jul; 31(3):197-200. PubMed ID: 21779195 [TBL] [Abstract][Full Text] [Related]
6. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy. Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639 [TBL] [Abstract][Full Text] [Related]
7. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer. Robinson ARL; Radhakrishnan R; Horvath R; Pandey S Intern Med J; 2017 Jul; 47(7):820-823. PubMed ID: 28677313 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer. Dubert M; Abihssira S; Diamantis S; Guenin R; Messaoudi R; Roux AL; Rouis K; Lillo A; Surgers L; Douard R; Julia P; Lebeaux D Infection; 2021 Apr; 49(2):345-348. PubMed ID: 32749595 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation. Spruijt LE; Mosch A; Hoffmann CFE; van Nieuwkoop C; Tijsterman JD; Zutt R; van der Gaag NA; Contarino MF J Parkinsons Dis; 2024; 14(5):1061-1069. PubMed ID: 38788088 [TBL] [Abstract][Full Text] [Related]
10. Healthcare-Associated Mycobacterium bovis-Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation. Meije Y; Martínez-Montauti J; Caylà JA; Loureiro J; Ortega L; Clemente M; Sanz X; Ricart M; Santomà MJ; Coll P; Sierra M; Calsina M; Vaqué M; Ruiz-Camps I; López-Sánchez C; Montes M; Ayestarán A; Carratalà J; Orcau À Clin Infect Dis; 2017 Oct; 65(7):1136-1143. PubMed ID: 28575173 [TBL] [Abstract][Full Text] [Related]
11. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report. Duvnjak P; Laguna M J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190 [TBL] [Abstract][Full Text] [Related]
12. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis. Parent ME; Richer M; Liang P Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727 [TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060 [TBL] [Abstract][Full Text] [Related]
17. A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer. Clérigo V; Castro A; Mourato T; Gomes C Acta Med Port; 2019 Apr; 32(4):316-320. PubMed ID: 31067427 [TBL] [Abstract][Full Text] [Related]
18. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415 [TBL] [Abstract][Full Text] [Related]
19. The fate of bacillus Calmette-Guerin after intravesical instillation. Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972 [TBL] [Abstract][Full Text] [Related]
20. Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy. Nielens N; Marot L; Baeck M Int J Infect Dis; 2022 Apr; 117():247-250. PubMed ID: 33984512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]